1. Home
  2. OEC vs LCTX Comparison

OEC vs LCTX Comparison

Compare OEC & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$4.96

Market Cap

319.6M

Sector

Industrials

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.84

Market Cap

366.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OEC
LCTX
Founded
1862
1990
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
366.2M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
OEC
LCTX
Price
$4.96
$1.84
Analyst Decision
Sell
Strong Buy
Analyst Count
4
3
Target Price
$6.44
$4.67
AVG Volume (30 Days)
776.7K
1.1M
Earning Date
05-15-2026
06-05-2026
Dividend Yield
1.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,806,700,000.00
$14,556,000.00
Revenue This Year
N/A
$6.32
Revenue Next Year
$3.06
$124.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$4.35
$0.37
52 Week High
$14.13
$2.09

Technical Indicators

Market Signals
Indicator
OEC
LCTX
Relative Strength Index (RSI) 34.82 52.67
Support Level $4.35 $1.55
Resistance Level $5.43 $1.84
Average True Range (ATR) 0.48 0.10
MACD -0.14 0.00
Stochastic Oscillator 0.21 58.90

Price Performance

Historical Comparison
OEC
LCTX

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: